Location History:
- Raleigh, NC (US) (2007 - 2011)
- Sanford, NC (US) (2007 - 2017)
Company Filing History:
Years Active: 2007-2017
Title: James M Kress: Innovator in Pharmaceutical Chemistry
Introduction
James M Kress is a notable inventor in the field of pharmaceutical chemistry. He has made significant contributions to the development of compounds that target various central nervous system disorders. His work is particularly focused on creating selective antagonists that can aid in the treatment of serious mental health conditions.
Latest Patents
James M Kress holds a patent for "Tetralin And Indane Derivatives And Uses Thereof." This patent describes compounds of the formula (I), or pharmaceutically acceptable salts thereof, wherein R2 is (CR3R4)n-NR5R6. These compounds are identified as selective antagonists of 5-HT6 and/or 5-HT2A. The patent also outlines compositions that include these compounds and their applications in preparing medicaments for treating various central nervous system disease states. These conditions include psychoses, schizophrenia, manic depressions, neurological disorders, memory disorders, attention deficit disorder, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, food uptake disorders, and Huntington's disease.
Career Highlights
James M Kress is associated with F. Hoffmann-La Roche AG, a leading global healthcare company. His work at this esteemed organization has allowed him to focus on innovative solutions for complex medical challenges. Despite having no patents listed under his name, his contributions to the field are noteworthy.
Collaborations
Throughout his career, James has collaborated with esteemed colleagues such as Robert Greenhouse and Ralph New Harris. These partnerships have likely enhanced the scope and impact of his research in pharmaceutical chemistry.
Conclusion
James M Kress is a dedicated inventor whose work in pharmaceutical chemistry has the potential to significantly improve treatments for various central nervous system disorders. His innovative approach and collaborations with other professionals in the field highlight his commitment to advancing medical science.